Your browser doesn't support javascript.
loading
A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes.
Shigematsu, Erina; Yamakawa, Tadashi; Oba, Mari S; Suzuki, Jun; Nagakura, Jo; Kadonosono, Kazuaki; Terauchi, Yasuo.
Affiliation
  • Shigematsu E; Department of Endocrinology and Diabetes, Yokohama Medical Center, 4-57 Urafunecho, Minamiku, Yokohama 232-0024, Japan.
  • Yamakawa T; Department of Endocrinology and Metabolism, Yokohama Medical Center, 3-60-2, Harajuku, Totukaku, Yokohama 234-8575, Japan.
  • Oba MS; These authors contributed equally to this work.
  • Suzuki J; Department of Endocrinology and Diabetes, Yokohama Medical Center, 4-57 Urafunecho, Minamiku, Yokohama 232-0024, Japan.
  • Nagakura J; These authors contributed equally to this work.
  • Kadonosono K; Department of Medical Statistics Faculty of Medicine, Toho University, 5-21-16 Oomorinishi, Ootaku, Tokyo 143-0015, Japan.
  • Terauchi Y; Department of Endocrinology and Diabetes, Yokohama Medical Center, 4-57 Urafunecho, Minamiku, Yokohama 232-0024, Japan.
J Clin Med Res ; 9(7): 567-572, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28611856
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Clin Med Res Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Clin Med Res Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Canada